Delivery Order SPE2DB20D3505-SPE2DB25FT8H7

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,734.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a firm fixed price and an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,065.70, is for the provision of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a firm fixed price delivery order that runs through January 29, 2025. There are no set-aside requirements for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,923.68, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for $7,436.58 and covers the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is a delivery order for the WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,172.14 firm fixed-price delivery order is for WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has a ceiling value of $6,633.97 and a period of performance through December 19, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,537.66, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. This is a firm fixed-price delivery order contract with a completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,098.89 Firm Fixed Price delivery order contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a $185,131.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 22, 2024 and covers the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT8H7
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,066.92 and an ultimate completion date of January 21, 2025. The contract provides WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, to support military healthcare programs.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/21/25, 10:08 AM